skip to main content

Muckle LLP supports Sunderland pharma firm in successful sale

23rd May 2019 | Corporate Finance
Muckle LLP supports Sunderland pharma firm in successful sale

We are delighted to have helped the management team of Sunderland based Rokshaw Ltd negotiate the successful sale of its business.

EMMAC Life Sciences Ltd, the European independent medical cannabis

company, has announced completion of the acquisition of the entire issued share

capital of Rokshaw, the leading UK specials manufacturer, by EMMAC’s UK subsidiary,

EMMAC U.K Limited.

Rokshaw’s management team was advised on the corporate finance legal matters

by partners Philip Clare and Adam Rayner and solicitor Stuart

Grieve.

Medical cannabis imports

Rokshaw is a leading GMP-certified lab, manufacturing a wide range of

specials bespoke to patient requirements to ensure that patients across the UK

receive the highest quality products.

The acquisition brings immediate revenues to the EMMAC Group and enables

EMMAC to import medical cannabis into the UK to meet the rapidly growing

demands of the market, led by regulatory change and the increasing requirement

for access to premium medical cannabis product.

Rokshaw will become EMMAC’s second GMP-certified lab, working in close

conjunction with its research and development facility in Spain.

Inward investment

Antonio Costanzo, CEO of EMMAC, commented: “This investment not only

brings with it an immediate revenue stream but also gives EMMAC immediate

access to the UK medical cannabis market with the opportunity to grow the

existing 45 people-strong team into a centre of medical cannabis excellence for

the UK. 

“Joining us are the two founders of Rokshaw who have vital experience

working in a highly regulated industry and bring with them a proven commitment

to delivering the highest quality products.”

Specialist expertise

Jonathan and Richard Hodgson, co-founders of Rokshaw, said: “We are very

pleased to join EMMAC and we share its vision for providing the highest quality

products and services to patients across the UK, and unlocking the potential

for the medical cannabis market to meet growing clinician and patient demand.

“We were also delighted with the legal support from Muckle LLP. Their

specialist pharma expertise and technical skill made our lives so much easier

and we don’t believe we could have received this level of support from any other

North East law firm.”

To learn more about how we can support your business, please contact Adam

Rayner on 0191 211 7962 or email [email protected].

Share this story...